Nuclear Safeguards Bill

Baroness Bloomfield of Hinton Waldrist Excerpts

2nd reading (Hansard): House of Lords
Wednesday 7th February 2018 Lords Chamber

[Baroness Bloomfield of Hinton Waldrist (Con)]

My Lords, I actually find it encouraging to see this important Bill arriving in your Lordship’s House so early in the year. In the informative briefing given to us by the Ministers and officials last week, we were told that many issues identified in the position papers published last summer are well on the way to being resolved, and this has to be good news. It is most important that there is a seamless transfer in safeguarding arrangements for the non-proliferation of nuclear materials, as well as for continued co-operation in nuclear research and the mobility of workers and trade in this important sector. Obviously, there are two remaining political issues which are material—namely, those that relate to a transition period or, even better, an extension of our membership of Euratom, as suggested by my noble friend Lady Neville-Rolfe, and the Henry VIII powers in Clause 2, which will allow the Secretary of State to amend existing Acts as new international agreements are negotiated. But other issues, such as the transfer of Euratom-owned equipment, the status of existing contracts between member states and the UK, and the presence of fissile material in the UK which is owned by another member state, are, we hear, well under way, and I am sure that we all look forward to being updated on their status.

We leave Euratom on 29 March next year, and it is essential that new reporting and verification processes are in place on the date. We need to have the correct number of inspectors recruited and trained by the Office for Nuclear Regulation, and I understand that we already have half the number in training and a further recruitment round is under way. Again, I look forward to my noble friend the Minister updating us on this issue and its impact on the budget for the ONR.

Of course, while we may no longer be a member of Euratom, many of the standards it sets are legally binding and arise from obligations to which the UK is in any event committed under the International Atomic Energy Agency, of which we were a founder member in 1957. But I welcome my noble friend’s commitment to adhere to the higher standards of Euratom. The UK must continue its leading role in the development of international security and safety standards, irrespective of our future relationship with Euratom. For this industry is extremely important to the UK; it employs 66,000 people, and we are a world leader in nuclear fusion technologies and are committed to maintaining this position. I strongly believe that putting our regulatory house in order at an early stage will generate the confidence necessary to attract further investment in the industry. I am reassured that the pace of negotiations with other member states will enable this to happen, for we need to see advances in nuclear technology—for example, into a new generation of small modular nuclear reactors, which may represent a cheaper and quicker way to generate the new, low-carbon power that the country needs.

Finally, I understand entirely that this Bill is concerned with safeguarding, not safety arrangements, and with a new legal and regulatory framework. Medical isotopes do not fall within the scope of the Bill, nor indeed of this department. However, practical arrangements for their continued import to the UK do not appear to be covered anywhere. Most are imported from eastern Europe and many have a shelf life of only two weeks. The potential disruption to their supply is causing concern to cancer sufferers and to the medical profession generally. I take this opportunity to thank the Minister for suggesting that he arrange a meeting between BEIS, the Treasury and interested parties to discuss this important area of real concern.